Showing results (721-730 of 759) with videos related to

Sort By:
Pageof 76
Pediatrics|October 4, 2023
Epidemiology and Severity of Illness of MIS-C and Kawasaki Disease During the COVID-19 PandemicMatthew J Molloy, Katherine A Auger, Matt Hall, et al.
The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccinesMichael E Wechsler, Adelmir Souza-Machado, Christine Xu, et al.
American Journal of Respiratory and Critical Care Medicine|October 28, 2025
Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma: The VESTIGE TrialCeleste Porsbjerg, Eleanor M Dunican, Njira L Lugogo, et al.
BMC Psychiatry|November 20, 2014
Design of an international multicentre RCT on group schema therapy for borderline personality disorderPim Wetzelaer, Joan Farrell, Silvia M A A Evers, et al.
JACC. Advances|January 6, 2025
Estimating the Risk of Cardiovascular Events in U.S. Veterans Using the SMART Risk ScoreSubhash Banerjee, Rick A Weideman, David A Jacob, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 4, 2013
The predictive value of the exercise ECG for major adverse cardiac events in patients who presented with chest pain in the emergency departmentJudith M Poldervaart, A Jacob Six, Barbra E Backus, et al.
Chest|February 26, 2022
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE TrialLawrence D Sher, Michael E Wechsler, Klaus F Rabe, et al.
Allergy|October 17, 2024
The IL-4-IL-4Rα axis modulates olfactory neuroimmune signaling to induce loss of smellYannis Hara, Mithilesh Kumar Jha, Jeremy Y Huang, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 18, 2024
Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 AsthmaIan D Pavord, Klaus F Rabe, Elliot Israel, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 11, 2013
Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onsetN Collongues, R Marignier, A Jacob, et al.
Pageof 76